The apnea-hypopnea index (AHI) has long been the cornerstone of obstructive sleep apnea (OSA) diagnosis and severity classification. While AHI remains an important clinical metric, growing evidence suggests it may not fully capture disease complexity or accurately predict cardiovascular risk.
This webinar explores the development of AHI, including its strengths and limitations. It examines hypoxic burden—an emerging metric that measures the cumulative impact of oxygen desaturation during sleep and may better predict cardiovascular events and mortality.
Participants will also learn how OSA phenotyping and precision medicine are advancing more personalized approaches to diagnosis and treatment.
Discover practical applications for sleep laboratories, home sleep apnea testing (HSAT) platforms, and cardiovascular screening, while exploring how multimodal OSA metrics may shape the future of clinical practice and improve patient outcomes.